Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer's ...

GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.

The American Telemedicine Association’s lobbying arm, ATA Action, acquired the Digital Therapeutics Alliance (DTA) in a bid ...

Plus Therapeutics shares are trading higher by 244% during Thursday's session. The company announced that the FDA accepted the name REYOBIQ for the company's lead asset. The ‘Trade of the Day ...

HOUSTON, March 20, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced ...

If you're like me, you've got thousands of photos on your phone of your kids, parents, grandparents, loved ones, and friends. And they're likely to stay there, forgotten until you go digging ...

SURESNES, France and CAMBRIDGE, Mass., March 19, 2025 (GLOBE NEWSWIRE) -- Servier, an independent global pharmaceutical group governed by a non-profit foundation, and Black Diamond Therapeutics ...

Fresh off a pivot from commercial pharma business to preclinical biotech, Aadi Bioscience has rebranded to better match its strategic reboot. The company will henceforth be known as Whitehawk ...

On Tuesday, Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stock is sliding. The company shared an update on Elevidys (delandistrogene moxeparvovec-rokl), the only approved gene therapy in patients with ...

Washington, March 18, 2025 — The World Bank Group convened the second annual Global Digital Summit today, bringing together public and private sector leaders to expand our digital technology ...

Peptris Technologies, an AI-powered drug discovery company, announced that it has entered into a licensing agreement with Revio Therapeutics, a specialty pharma start-up focused on repurposing and ...